Effectiveness of an Evidence-Based Respiratory and Renal Care Training With Case-Based Discussion on Nurses' Clinical Reasoning, Knowledge & Practice, Nurse-Physician Collaboration and Mechanically Ventilated Patient Outcomes in a Tertiary-Level ICU in Bangladesh
This study will evaluate the effectiveness of an evidence-based respiratory and renal care training program combined with case-based discussion on nurses' clinical reasoning, knowledge & practice, nurse-physician collaboration, as well as selected clinical outcomes among mechanically ventilated patients in a tertiary-level ICU in Bangladesh.
The intervention will provide structured education and practical training to ICU nurses on evidence-based respiratory and renal care for mechanically ventilated patients. Case-based discussions will be conducted to promote clinical reasoning, evidence-based decision-making, and nurse-physician collaboration during daily ICU rounds.
Nurses' outcomes will be assessed before and after the intervention, focusing on clinical reasoning, knowledge, practice, and nurse-physician collaboration.
Patient outcomes will be assessed using historical pre-intervention data and post-intervention data among eligible mechanically ventilated ICU patients, focusing on ventilator-associated events (VAE), ventilator-associated pneumonia (VAP), Acute Kidney Injury (AKI), duration of mechanical ventilation, ICU length of stay, and ICU mortality.
The study is intended to determine whether evidence-based respiratory and renal care training with case-based discussion can improve ICU nurses' clinical reasoning, knowledge, practice, nurse-physician collaboration and contribute to improved outcomes among mechanically ventilated patients.
Visão geral do estudo
Status
Intervenção / Tratamento
Descrição detalhada
Background and Rationale:
Critically ill patients requiring mechanical ventilation are at high risk of complications related to respiratory and renal dysfunction, including ventilator-associated events (VAE), ventilator-associated pneumonia (VAP), acute kidney injury (AKI), prolonged mechanical ventilation, prolonged intensive care unit (ICU) stay, and death. Prevention, early recognition, and appropriate management of these complications require ICU nurses to possess adequate knowledge, clinical reasoning ability, practical skills, and effective communication and collaboration with physicians and other members of the ICU team.
In resource-limited settings, including Bangladesh, gaps in ICU staffing, continuing professional education, standardized clinical practices, and multidisciplinary communication may affect the quality and safety of care provided to mechanically ventilated patients. Evidence-based training that combines theoretical education with practical application and case-based clinical discussion may improve nurses' ability to recognize patient deterioration, interpret clinical findings, apply evidence-based interventions, and communicate effectively with physicians and other ICU professionals.
This study will evaluate an evidence-based respiratory and renal care training program combined with structured case-based discussion for ICU nurses in a tertiary-level ICU in Bangladesh. The intervention is designed to strengthen nurses' clinical reasoning, knowledge, clinical practice, and nurse-physician collaboration in the care of mechanically ventilated patients.
The study will also examine whether improvements in nursing competency and collaborative clinical decision-making are associated with improved patient outcomes.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Mina AKTER, Doctoral Student
- Número de telefone: +8801749211811, +81-0709094627
- E-mail: minajack417@gmail.com
Estude backup de contato
- Nome: Dr. Subrata Kumar Mondal, MBBS, MCPS, DA, FCPS
- Número de telefone: +88-01715437240
- E-mail: subrata326@yahoo.com
Locais de estudo
-
-
Dhaka Division
-
Dhaka, Dhaka Division, Bangladesh, 1000
- Dhaka Medical College & Hospital
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
For nurses:
- Registered nurses employed in the ICU at the time of enrollment
- Involved in direct patient care
- Willing to participate and provide informed written consent
For Patients:
- Age ≥18 years
- Patients receive mechanical ventilation for at least ≥ 48 hours
- Legal guardian of the patients who will provide informed written consent
Exclusion Criteria:
For nurses:
- Nurses on long-term leave and study leave during the intervention period
- Nurses working exclusively in administrative or managerial roles
- Nurses who did not complete the pre-test assessment
For Patients:
- Patients mechanically ventilated for less than 48 hours.
- Patients who have already developed VAE or VAP at ICU admission
- Patients with end-stage renal disease on chronic dialysis prior to ICU admission
- Readmissions to ICU during the same hospital stay
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Prevenção
- Alocação: Não randomizado
- Modelo Intervencional: Atribuição sequencial
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Sem intervenção: Historical Control group-Eligible mechanically ventilated ICU patients with usual standard care
Eligible mechanically ventilated ICU patients received usual standard ICU care before implementation of the intervention.
Historical patient data will be collected from medical records.
ICU nurses will be assessed at baseline before receiving the intervention.
No study intervention was administered during this phase.
|
|
|
Experimental: Experimental-Eligible mechanically ventilated ICU patients with intervention
ICU nurses will receive evidence-based respiratory and renal care training with case-based discussion to strengthen clinical reasoning, nurse-physician collaboration, and application of evidence-based ICU care.
Eligible mechanically ventilated ICU patients will receive evidence based care after implementation of the intervention, and their outcomes will be measured.
|
The intervention will be provided over 2 months period. The evidence-based respiratory and renal care training will address respiratory assessment and monitoring, oxygen therapy and airway care, mechanical ventilation basics and ventilator care bundle practices, sedation, weaning and early mobilization, renal assessment and early detection of AKI based on kidney disease: Improving Global Outcomes (KDIGO) criteria, AKI prevention & Renal Care Bundle, fluid balance and hemodynamic monitoring, Electrolyte & Acid-Base Management. During daily ICU rounds, 10-15-minute bedside case discussions will be conducted for each mechanically ventilated ICU patients. An ICU consultant will facilitate the discussion using the ISBAR framework, involving the bedside nurse and other ICU team members. Each discussion will focus on the patient's current clinical condition, respiratory and renal assessment, interpretation of clinical findings, evidence-based care decisions, and appropriate management. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Incidence Rate of Ventilator-Associated Events
Prazo: During the 2-month pre-intervention and the 2-month post-intervention observation period
|
The incidence rate of ventilator-associated events (VAE) among eligible mechanically ventilated ICU patients will be calculated as the number of VAE cases divided by the total number of ventilator days, multiplied by 1,000.
VAE incidence will be compared between the pre-intervention and post-intervention periods.
|
During the 2-month pre-intervention and the 2-month post-intervention observation period
|
|
Change in Clinical Reasoning Competency Score
Prazo: Baseline, midline, and 2-month post-intervention follow-up (endline)
|
Clinical reasoning will be measured among participating ICU nurses using the 22-item Clinical Reasoning Competency Scale developed by Bae et al. (2023).
Each item is rated on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree), with a total score ranging from 22 to 110.
Higher scores indicate greater clinical reasoning competency.
The total CRCS score will be assessed at baseline, midline, and endline.
Baseline assessment will be conducted before the intervention, midline assessment will be conducted during the intervention period, and endline assessment will be conducted 2 months after completion of the intervention as a post-intervention follow-up.
Changes in clinical reasoning competency across the three assessment time points will be evaluated.
|
Baseline, midline, and 2-month post-intervention follow-up (endline)
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in Knowledge Score
Prazo: Baseline, immediately post-intervention (midline), and 2-month post-intervention follow-up (endline)
|
knowledge will be assessed among participating ICU nurses using a 50-item researcher-developed multiple-choice questionnaire.
Each correct response will receive one point, resulting in a total score ranging from 0 to 50.
Higher scores indicate greater knowledge.
The total knowledge score will be assessed at baseline, midline, and endline.
Changes in knowledge across the three assessment time points will be evaluated.
|
Baseline, immediately post-intervention (midline), and 2-month post-intervention follow-up (endline)
|
|
Change in Nurses Practice Score
Prazo: Baseline, immediately post-intervention (midline), and 2-month post-intervention follow-up (endline)
|
ICU nurses practice will be assessed among participating ICU nurses using a 40-item practice checklist covering evidence-based respiratory and renal care practices.
The total practice score will be calculated according to the predefined scoring procedure, with higher scores indicating better adherence to recommended clinical practices.
The practice score will be assessed at baseline, midline, and endline.
Changes in nursing practice across the three assessment time points will be evaluated.
|
Baseline, immediately post-intervention (midline), and 2-month post-intervention follow-up (endline)
|
|
Incidence Rate of Ventilator-Associated Pneumonia
Prazo: During the 2-month pre-intervention and the 2-month post-intervention observation period
|
The incidence rate of ventilator-associated pneumonia (VAP) will be assessed among eligible mechanically ventilated ICU patients.
VAP will be identified according to the predefined diagnostic criteria specified in the study protocol.
The VAP incidence rate will be calculated as the number of VAP cases divided by the total number of ventilator days, multiplied by 1,000.
The incidence rate will be compared between the pre-intervention and post-intervention periods.
|
During the 2-month pre-intervention and the 2-month post-intervention observation period
|
|
Incidence of Acute Kidney Injury
Prazo: During the 2-month pre-intervention and the 2-month post-intervention observation period
|
The incidence of acute kidney injury (AKI) will be assessed among eligible ICU patients according to the Kidney Disease: Improving Global Outcomes (KDIGO) criteria.
AKI will be identified based on the predefined clinical and laboratory criteria specified in the study protocol.
The proportion of patients who develop AKI during their ICU stay will be compared between the pre-intervention and post-intervention periods.
|
During the 2-month pre-intervention and the 2-month post-intervention observation period
|
|
ICU Mortality
Prazo: During the 2-month pre-intervention and the 2-month post-intervention observation period
|
ICU mortality will be defined as death occurring during the ICU admission among eligible patients.
The proportion of patients who die during their ICU stay will be compared between the pre-intervention and post-intervention periods.
|
During the 2-month pre-intervention and the 2-month post-intervention observation period
|
|
Duration of Mechanical Ventilation
Prazo: During the 2-month pre-intervention and the 2-month post-intervention observation period
|
Duration of mechanical ventilation will be measured as the number of days from initiation of invasive mechanical ventilation until successful discontinuation of mechanical ventilation.
The duration of mechanical ventilation will be compared between eligible patients in the pre-intervention and post-intervention periods.
|
During the 2-month pre-intervention and the 2-month post-intervention observation period
|
|
ICU Length of Stay
Prazo: During the 2-month pre-intervention and the 2-month post-intervention observation period
|
ICU length of stay will be measured as the number of days from ICU admission until ICU discharge or death.
ICU length of stay will be compared between eligible patients in the pre-intervention and post-intervention periods.
|
During the 2-month pre-intervention and the 2-month post-intervention observation period
|
|
Change in Nurse-Physician Collaboration Score
Prazo: Baseline, immediately post-intervention (midline), and 2-month post-intervention follow-up (endline)
|
Nurse-physician collaboration will be assessed among participating ICU nurses using the Nurse-Physician Collaboration Scale developed by Ushiro (2009).Each item is rated on a 5-point Likert scale (1 = always to 5 = never), with a total score ranging from 27 to 135.
Higher scores indicate poorer nurse-physician collaboration.
Baseline assessment will be conducted before the intervention, midline assessment immediately after completion of the training intervention, and endline assessment 2 months after completion of the intervention as a post-intervention follow-up.
Changes in nurse-physician collaboration across the three assessment time points will be evaluated.
|
Baseline, immediately post-intervention (midline), and 2-month post-intervention follow-up (endline)
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Diretor de estudo: Michiko Moriyama, PhD, Professor, Division of Nursing Science, Graduate School of Biomedical and Health Sciences ,Hiroshima University,Japan
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- BMRC/NREC/2025-2027/201
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .